Psychiatry & Neurology Doctors in Boonton, NJ Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Dr. Sarabjit Singh, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 130 Powerville Rd, Boonton, NJ 07005 Phone: 973-316-1802    Fax: 973-316-1815

Jeffrey Ilardi, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 130 Powerville Rd, Boonton, NJ 07005 Phone: 973-299-5456    Fax: 973-316-1839

Dr. Suman Lata Jalan, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 130 Powerville Rd, Boonton, NJ 07005 Phone: 973-299-5463

Dr. Dennis Joel Massler, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 16 Meadowbrook Rd, Boonton, NJ 07005 Phone: 973-331-8119    Fax: 973-588-4669

News Archive

Sanofi-aventis commences tender offer for Genzyme acquisition

Sanofi-aventis announced today it has commenced a tender offer for all outstanding shares of common stock of Genzyme Corporation for $69 per share, net to the seller in cash, without interest and less any required withholding taxes. The transaction is valued at approximately $18.5 billion.

Accuray: Mount Vernon Cancer Centre acquires CyberKnife Robotic Radiosurgery System

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that Mount Vernon Cancer Centre in the United Kingdom has become the first National Health Service hospital to acquire a CyberKnife® Robotic Radiosurgery System.

AAWC develops series of brochures in Spanish for skin care and treatment of wounds

The Association for the Advancement of Wound Care has developed three educational brochures for the care of skin and treatment of wounds. Widely used by clinicians as a resource for patients and their caregivers, AAWC recently converted the brochures into Spanish due to popular demand.

S1P1R variation may cause differential patient responses to fingolimod treatment

Multiple sclerosis (MS) is an autoimmune disorder that results in demyelination of neurons. The FDA-approved drug fingolimod (Gilenya, FTY-720) modulates signaling by the bioactive lipid sphingosine-1-phosphate (S1P), which is linked to MS pathogenesis.

Read more Medical News

› Verified 2 days ago